Financials
- Market Capitalization 1.75 B
- Employee 298
- Founded 2005
- CEO N/A
- Website www.syndax.com
- Headquarter Delaware, United States
- FIGI BBG000R33JY1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.39
Relación precio/flujo de caja
10.56
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2082 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.81 USD | -2.29% | -0.70% | +18.94% | -6.63% | 1.80 B USD | ||
| 2085 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.35 USD | -2.62% | -4.56% | +10.56% | -30.93% | 1.79 B USD | ||
| 2110 | GHRS GH Research PLC - Ordinary Shares | 27.98 USD | -2.34% | -0.92% | +0.14% | +97.60% | 1.74 B USD | ||
| 2122 | AAPG Ascentage Pharma Group International - American Depository Shar | 18.28 USD | -2.40% | +8.62% | -0.16% | -26.88% | 1.71 B USD |